A detailed history of American Century Companies Inc transactions in Standard Biotools Inc. stock. As of the latest transaction made, American Century Companies Inc holds 183,290 shares of LAB stock, worth $267,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares
183,290
Previous 97,307 88.36%
Holding current value
$267,603
Previous $172,000 105.23%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.42 - $2.35 $122,095 - $202,060
85,983 Added 88.36%
183,290 $353,000
Q2 2024

Aug 07, 2024

BUY
$1.65 - $2.92 $117,024 - $207,098
70,924 Added 268.82%
97,307 $172,000
Q1 2024

May 14, 2024

BUY
$1.87 - $2.78 $49,336 - $73,344
26,383 New
26,383 $71,000
Q4 2020

Feb 12, 2021

SELL
$5.45 - $8.65 $149,716 - $237,624
-27,471 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$4.34 - $11.43 $119,224 - $313,993
27,471 New
27,471 $204,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $115M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.